Cited by

• Safety and Efficacy of Switching Patients With Type 2 Diabetes From Glucagon-Like Peptide-1 Receptor Agonists to Tirzepatide: A Case Series.

  Barakat S, Ramdeen S, Khaimova R. Barakat S, et al. Hosp Pharm. 2024 Dec;59(6):614-619. doi: 10.1177/00185787241266803. Epub 2024 Aug 5. Hosp Pharm. 2024. PMID: 39449861
• Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments.

  Crescioli G, Bettiol A, Bonaiuti R, Tuccori M, Rossi M, Capuano A, Pagani S, Spada G, Venegoni M, Vighi GD, Mannaioni G, Vannacci A, Lombardi N; MEREAFaPS Study group. Crescioli G, et al. Front Pharmacol. 2021 Jan 29;11:611102. doi: 10.3389/fphar.2020.611102. eCollection 2020. Front Pharmacol. 2021. PMID: 33708120 Free PMC article.
• Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.

  Théophile H, André M, Miremont-Salamé G, Arimone Y, Bégaud B. Théophile H, et al. Drug Saf. 2013 Oct;36(10):1033-44. doi: 10.1007/s40264-013-0083-1. Drug Saf. 2013. PMID: 23828659 Clinical Trial.
• Treatment of toxoplasmic encephalitis with the combination of clindamycin plus azithromycin in an HIV-infected patient: A case report.

  Mohammadi K, Khalili H, Jafari S, Yaribash S. Mohammadi K, et al. Clin Case Rep. 2021 Mar 24;9(5):e04045. doi: 10.1002/ccr3.4045. eCollection 2021 May. Clin Case Rep. 2021. PMID: 34084486 Free PMC article.
• Fatal case of cryptogenic organizing pneumonia associated with everolimus.

  Nazer L, Alnajjar T, Salah S, Khzouz J, Alfaqeer N, Qandeel M. Nazer L, et al. Ann Saudi Med. 2014 Sep-Oct;34(5):437-9. doi: 10.5144/0256-4947.2014.437. Ann Saudi Med. 2014. PMID: 25827702 Free PMC article.